iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Textual)

Stockholders' Equity (Details Textual) - USD ($)					1 Months Ended						6 Months Ended
Stockholders' Equity (Details Textual) - USD ($)	Apr. 13, 2016	Apr. 07, 2016	Jan. 13, 2016	May 15, 2015	Feb. 15, 2018	Dec. 31, 2017	Nov. 30, 2017	Jul. 24, 2017	Feb. 23, 2017	Jan. 25, 2016	Dec. 31, 2017	Dec. 31, 2016	Jun. 30, 2017
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized						1,000,000			1,000,000		1,000,000		1,000,000
Common Stock, Shares Authorized						275,000,000					275,000,000		175,000,000
Common Stock, Shares, Issued						115,318,510		1,200,000			115,318,510		89,118,510
Stock Issued During Period, Shares, New Issues	6,500,000						22,500,000
Stock Issued During Period, Value, New Issues	$ 4,043,000						$ 4,500,000	$ 1,000,000			$ 5,500,000
Share Price								$ 0.40
Shares Issued, Price Per Share							$ 0.20
Registration Common Stock						$ 15,000,000					$ 15,000,000
Common Stock, Par or Stated Value Per Share						$ 0.001					$ 0.001		$ 0.001
Offering Price To New Investors							7.00%
Offering Price to Existing Investors							3.50%
Underwriting Discounts, Commissions and Other Offering Expenses							$ 311,000
Proceeds from Noncontrolling Interests											$ 1,050,000	$ 0
Stockholders [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, Other		6,500,000
Over-Allotment Option [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, New Issues							110,000
Subsequent Event [Member]
Stockholders' Equity [Line Items]
Payments to Acquire Interest in Subsidiaries and Affiliates					$ 3,500,000
Eastern Share Purchase Agreements [Member]
Stockholders' Equity [Line Items]
Proceeds from Warrant Exercises										$ 945,000
Stock Issued During Period, Value, New Issues			$ 0.622							$ 2,177,000
Stock Issued During Period, Shares, Other			6,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights										$ 0.53
Stock Issued During Period, Shares, Acquisitions			3,500,000
Common Stock, Par or Stated Value Per Share			$ 0.622
Class Of Warrants Or Rights Exercised										1,784,000
Maximum Common Stock Percentage			38.00%
Equity Method Investment, Ownership Percentage						40.00%					40.00%
Lincoln Park Purchase Agreement [Member]
Stockholders' Equity [Line Items]
Aggregate Common Stock Purchased								$ 16,000,000
Stock Issued During Period, Shares, New Issues								2,500,000
Stock Issued During Period, Shares, Other								100,000
Share Price								$ 0.25
Additional Aggregate Common Stock Purchased								$ 15,000,000
Aspire Capital Fund, LLC 2014 [Member]
Stockholders' Equity [Line Items]
Aggregate Common Stock Purchased				$ 15,000,000
Aspire Capital Fund, LLC 2015 [Member]
Stockholders' Equity [Line Items]
Commitment Shares Issued During Period				450,000
Preferred Tracking Stock [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, New Issues									13,000,000
Stock Issued During Period, Value, New Issues									$ 13,000,000
Preferred Stock, Dividend Rate, Percentage											2.00%
Dividends Payable						$ 222,000					$ 222,000
Convertible Preferred Stock, Shares Issued upon Conversion									29,990,000
Preferred Stock, Par or Stated Value Per Share									$ 0.001
Noncontrolling Interest, Ownership Percentage by Parent									9.99%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners									0.01%
iBio CDMO [Member]
Stockholders' Equity [Line Items]
Proceeds from Noncontrolling Interests						$ 1,050,000
Maximum [Member] \| Lincoln Park Purchase Agreement [Member]
Stockholders' Equity [Line Items]
Aggregate Common Stock Purchased								$ 1,000,000